Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.
The report details the trend, potential and market size of Injectable Anticoagulants market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Injectable Anticoagulantsmarket, defines the market attractiveness level of Injectable Anticoagulants market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Injectable Anticoagulants industry, describes the types of Injectable Anticoagulants market, the applications of major players and the market size, and deeply analyzes the current situation of the global Injectable Anticoagulants market and the development prospects and opportunities of Injectable Anticoagulants industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Injectable Anticoagulants market in Chapter 13.
By Player:
Aspen
Boehringer Ingelheim
Pfizer
The Medicines Company
Otsuka
Genentech (Roche)
Sanofi
By Type:
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other
By End-User:
VTE
ACS/MI
AF
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Injectable Anticoagulants Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Injectable Anticoagulants Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Injectable Anticoagulants Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Injectable Anticoagulants Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Injectable Anticoagulants Market Analysis and Outlook to 2022
-
7.1 Global Injectable Anticoagulants Consumption (2017-2022)
-
7.2 United States Injectable Anticoagulants Consumption (2017-2022)
-
7.3 Europe Injectable Anticoagulants Consumption (2017-2022)
-
7.4 China Injectable Anticoagulants Consumption (2017-2022)
-
7.5 Japan Injectable Anticoagulants Consumption (2017-2022)
-
7.6 India Injectable Anticoagulants Consumption (2017-2022)
-
7.7 South Korea Injectable Anticoagulants Consumption (2017-2022)
8 Region and Country-wise Injectable Anticoagulants Market Analysis and Outlook to 2028
-
8.1 Global Injectable Anticoagulants Consumption Forecast (2022-2028)
-
8.2 United States Injectable Anticoagulants Consumption Forecast (2022-2028)
-
8.3 Europe Injectable Anticoagulants Consumption Forecast (2022-2028)
-
8.4 China Injectable Anticoagulants Consumption Forecast (2022-2028)
-
8.5 Japan Injectable Anticoagulants Consumption Forecast (2022-2028)
-
8.6 India Injectable Anticoagulants Consumption Forecast (2022-2028)
-
8.7 South Korea Injectable Anticoagulants Consumption Forecast (2022-2028)
9 Global Injectable Anticoagulants Market Outlook by Types and Applications to 2022
-
9.1 Global Injectable Anticoagulants Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Low-molecular-weight Heparin (LMWH) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Direct Thrombin Inhibitor (DTI) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Injectable Anticoagulants Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global VTE Consumption and Growth Rate (2017-2022)
-
9.2.2 Global ACS/MI Consumption and Growth Rate (2017-2022)
-
9.2.3 Global AF Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Injectable Anticoagulants Market Outlook by Types and Applications to 2028
-
10.1 Global Injectable Anticoagulants Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Low-molecular-weight Heparin (LMWH) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Direct Thrombin Inhibitor (DTI) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Injectable Anticoagulants Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global VTE Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global ACS/MI Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global AF Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Injectable Anticoagulants Import and Export Analysis (Top 5 Countries)
-
11.1 Global Injectable Anticoagulants Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Injectable Anticoagulants Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Injectable Anticoagulants Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Injectable Anticoagulants Market Competitive Analysis
-
14.1 Aspen
-
14.1.1 Aspen Company Details
-
14.1.2 Aspen Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Aspen Injectable Anticoagulants Product and Service
-
14.2 Boehringer Ingelheim
-
14.2.1 Boehringer Ingelheim Company Details
-
14.2.2 Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Boehringer Ingelheim Injectable Anticoagulants Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Injectable Anticoagulants Product and Service
-
14.4 The Medicines Company
-
14.4.1 The Medicines Company Company Details
-
14.4.2 The Medicines Company Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 The Medicines Company Injectable Anticoagulants Product and Service
-
14.5 Otsuka
-
14.5.1 Otsuka Company Details
-
14.5.2 Otsuka Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Otsuka Injectable Anticoagulants Product and Service
-
14.6 Genentech (Roche)
-
14.6.1 Genentech (Roche) Company Details
-
14.6.2 Genentech (Roche) Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Genentech (Roche) Injectable Anticoagulants Product and Service
-
14.7 Sanofi
-
14.7.1 Sanofi Company Details
-
14.7.2 Sanofi Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi Injectable Anticoagulants Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Injectable Anticoagulants
-
Figure Injectable Anticoagulants Picture
-
Table Global Injectable Anticoagulants Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Injectable Anticoagulants Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Injectable Anticoagulants Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Injectable Anticoagulants Consumption by Country (2017-2022)
-
Figure United States Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Table Europe Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure China Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Japan Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure India Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure South Korea Injectable Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Global Injectable Anticoagulants Consumption Forecast by Country (2022-2028)
-
Figure United States Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Injectable Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Low-molecular-weight Heparin (LMWH) Consumption and Growth Rate (2017-2022)
-
Figure Global Direct Thrombin Inhibitor (DTI) Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global VTE Consumption and Growth Rate (2017-2022)
-
Figure Global ACS/MI Consumption and Growth Rate (2017-2022)
-
Figure Global AF Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Low-molecular-weight Heparin (LMWH) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Direct Thrombin Inhibitor (DTI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global VTE Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ACS/MI Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AF Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Injectable Anticoagulants Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Injectable Anticoagulants Export by Region (Top 5 Countries) (2017-2028)
-
Table Aspen (Foundation Year, Company Profile and etc.)
-
Table Aspen Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aspen Injectable Anticoagulants Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Injectable Anticoagulants Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Injectable Anticoagulants Product and Service
-
Table The Medicines Company (Foundation Year, Company Profile and etc.)
-
Table The Medicines Company Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table The Medicines Company Injectable Anticoagulants Product and Service
-
Table Otsuka (Foundation Year, Company Profile and etc.)
-
Table Otsuka Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Injectable Anticoagulants Product and Service
-
Table Genentech (Roche) (Foundation Year, Company Profile and etc.)
-
Table Genentech (Roche) Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech (Roche) Injectable Anticoagulants Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Injectable Anticoagulants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Injectable Anticoagulants Product and Service
-
